SynthesisPloS one2019

A meta-analysis of randomized controlled trials that compare standard doxorubicin with other first-line chemotherapies for advanced/metastatic soft tissue sarcomas.

Kazuhiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.